These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2547603)

  • 1. Leukotrienes and the airways.
    Piper PJ
    Eur J Anaesthesiol; 1989 Jul; 6(4):241-55. PubMed ID: 2547603
    [No Abstract]   [Full Text] [Related]  

  • 2. WY-50,295 tromethamine: a novel inhibitor of leukotriene-mediated reactions.
    Weichman BM; Berkenkopf JW; Grimes D; Heaslip RJ; Sturm RJ; Chang JY
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():477-80. PubMed ID: 1847784
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of the production and action of leukotrienes by MK-571 and MK-886.
    Ford-Hutchinson AW
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():9-16. PubMed ID: 1847788
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of leukotriene D4 receptor antagonists and 5-lipoxygenase inhibitors to define a role for leukotrienes in allergic reactions.
    Ford-Hutchinson AW
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():507-10. PubMed ID: 2546393
    [No Abstract]   [Full Text] [Related]  

  • 5. Leukotrienes in respiratory disease.
    McMillan RM
    Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases.
    Lewis RA; Austen KF; Soberman RJ
    N Engl J Med; 1990 Sep; 323(10):645-55. PubMed ID: 2166915
    [No Abstract]   [Full Text] [Related]  

  • 7. Structural analysis of sulfido-peptide leukotrienes: application to the design of potent and specific antagonists of leukotriene D4.
    Young RN
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():643-6. PubMed ID: 2546403
    [No Abstract]   [Full Text] [Related]  

  • 8. New frontiers in asthma therapy: leukotriene receptor antagonists and 5-lipoxygenase inhibitors. Introduction.
    Hendeles L
    Pharmacotherapy; 1997; 17(1 Pt 2):1S-2S. PubMed ID: 9017782
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of cysteinyl leukotrienes in spontaneous asthmatic responses.
    Drazen JM; Lilly CM; Sperling R; Rubin P; Israel E
    Adv Prostaglandin Thromboxane Leukot Res; 1994; 22():251-62. PubMed ID: 7771339
    [No Abstract]   [Full Text] [Related]  

  • 10. [Allergy and leukotrienes].
    Ado VA; Mokronosova MA; Perlamutrov IuN
    Klin Med (Mosk); 1995; 73(2):9-12. PubMed ID: 7609435
    [No Abstract]   [Full Text] [Related]  

  • 11. Leukotrienes and inflammation.
    Busse WW
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S210-3; discussion S247-8. PubMed ID: 9647601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfidopeptide leukotrienes mediate acrolein-induced bronchial hyperresponsiveness.
    Leikauf GD; Doupnik CA; Leming LM; Wey HE
    J Appl Physiol (1985); 1989 Apr; 66(4):1838-45. PubMed ID: 2543658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotrienes: lipid bioeffectors of inflammatory reactions.
    Sala A; Zarini S; Bolla M
    Biochemistry (Mosc); 1998 Jan; 63(1):84-92. PubMed ID: 9526099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotrienes mediate 5-hydroxytryptamine-induced plasma extravasation in the rat knee joint via CysLT-type receptors.
    Wang Y; Mitchell J; Sharma M; Gabriel A; Moriyama K; Palmer PP
    Inflamm Res; 2004 Feb; 53(2):66-71. PubMed ID: 15021971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotrienes and human airways.
    Piper PJ; Samhoun MN; Conroy DM; Barnes NC; Evans J; Costello JF
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():488-94. PubMed ID: 2526524
    [No Abstract]   [Full Text] [Related]  

  • 16. [The significance of leukotrienes in pathophysiology of bronchial asthma--therapy perspectives].
    Wojnowski P; Patkowski J
    Postepy Hig Med Dosw; 1997; 51(5):499-514. PubMed ID: 9489451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitors of 5-lipoxygenase].
    Gápovský M; Remko M
    Ceska Slov Farm; 2002 Mar; 51(2):55-62. PubMed ID: 11928277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma.
    Drazen JM
    Pharmacotherapy; 1997; 17(1 Pt 2):22S-30S. PubMed ID: 9017785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
    Jonsson EW
    Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulators of leukotriene biosynthesis and receptor activation.
    Brooks CD; Summers JB
    J Med Chem; 1996 Jul; 39(14):2629-54. PubMed ID: 8709092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.